For years, scientists have documented the gut microbiome’s far-reaching influence on health, from metabolism to immunity. In female reproductive biology, the connection is especially intricate: gut bacteria help metabolize estrogens, and imbalances have been tied to conditions like polycystic ovary syndrome. So, when researchers at the University of Southern California decided to test how an aged intestinal ecosystem affects ovarian function, they expected trouble. Instead, they got a boost.
“We originally hypothesized that receiving an aged microbiome would harm the ovaries,” said Ming Hu Kim, first author of the study and a researcher in the lab of Berenice Benayoun. “To our amazement, we found the opposite.” The team discovered that young mice given fecal microbiota transplants (FMT) from old females produced more offspring, became pregnant faster, and displayed molecular signatures of younger ovaries – upending conventional narratives around microbial aging.
Experimental Part Unfolded
The scientists began by wiping out the native gut microbes of young adult female mice using a mix of antibiotics and antifungals. They then transplanted fecal material from two donor groups: female mice of a similar young age, and females in “estropause” – a mouse counterpart to human menopause, when ovarian responsiveness to hormonal signals dwindles.
After the transplants, the team tracked reproductive outcomes and analyzed ovarian tissue, blood metabolites, and the gut’s bacterial composition through 16S rRNA gene sequencing and RNA sequencing. The contrasts were stark. Mice receiving microbes from aged donors universally gave birth during the observation period, while some recipients of young-derived microbiota never reproduced. On average, the “old-microbiome” group had more pups per litter and a shorter time between first mating and delivery.
Rejuvenation at the Molecular Level
Beyond fertility metrics, the ovaries of young recipients looked younger at the transcriptomic level. RNA profiles shifted toward patterns typical of more youthful ovaries, with dampened expression of genes linked to inflammation – a hallmark of aging tissues. These changes suggest that the microbial transplant didn’t just mask age-related decline but actively nudged ovarian cells toward a more resilient state.
The microbial makeup itself offered clues. Certain bacterial species, including Bacteroides xylanisolvens, B. thetaiotaomicron, and Parabacteroides distasonis, are often found at higher abundances in polycystic ovary syndrome. In contrast, these same bugs were less abundant in mice that had received the estropausal microbiome. The researchers also pinpointed candidates – such as B. zhangwenhongii and Shigella flexneri – that might be driving the observed transcriptomic remodeling or influencing hormone levels.
Metabolite profiles in the blood further illustrated the transformation. Notably, serum levels of estradiol, a primary estrogen, were actually lower in the mice that had received aged microbiota, yet computational predictions indicated higher activity of β-glucuronidase, a bacterial enzyme that can increase estrogen bioavailability locally. This paradox hints at a more refined hormonal regulation – one that tweaks estrogen metabolism without raising baseline blood levels.
The Estrobolome’s Compensatory Signal
How could an “old” microbial community improve fertility? The researchers point to the estrobolome – the collection of microbial genes involved in estrogen processing. As a host ages and ovarian sensitivity fades, the estrobolome may try to compensate by amplifying signaling molecules. When transplanted into a young recipient whose ovaries remain highly responsive, that louder signal could translate into a meaningful physiological boost.
This compensatory model aligns with earlier findings. Other studies have reported that FMT from aged donors can benefit young recipients, for instance by enhancing neurogenesis in the hippocampus. The gut microbiome, it seems, sometimes mounts a protective response to the body’s own decline – a phenomenon that becomes visible only when the recipient’s tissues can still interpret the cues.
Broader Implications
Ovarian aging isn’t just about fertility – it increases risks for osteoporosis, cardiovascular disease, and dementia, and early menopause is linked to shorter lifespan. If microbiome-based interventions could slow this clock, they might impact a whole suite of age-related conditions. The USC team stresses that more work is needed to see whether these findings translate to human health, but the concept of deliberately shaping the gut ecosystem to support reproductive longevity is now firmly on the table.
“We are only beginning to understand the dialogue between gut microbes and the ovaries,” Benayoun noted. “The fact that an aged microbiome can carry beneficial signals underscores how complex this relationship is.” As researchers investigate pathways involving vitamin K2 and CD38-NAD metabolism, the hope is that one day a tailored microbial therapy could help extend women’s healthspan – long before the first hot flash appears.
Publication date: 2026.03.13
Source: Kim M. et al. Estropausal gut microbiota transplant improves measures of ovarian function in adult mice. Nat Aging. 2026 Mar;6(3):682-702. doi: 10.1038/s43587-026-01069-3. Epub 2026 Mar 3. PMID: 41776310; PMCID: PMC13004687. https://www.nature.com/articles/s43587-026-01069-3